Izvorni znanstveni članak

https://doi.org/10.20471/acc.2022.61.04.12

The Effect of COVID-19 Vaccines on Pneumothorax in Geriatric Patients Hospitalized in Intensive Care Unit Due to COVID-1

Anil Gokce ; University of Health Sciences, Ankara City Hospital, Department of Thoracic Surgery, Bilkent, Ankara, Turkey
Merve Hatipoglu ; University of Health Sciences, Ankara City Hospital, Department of Thoracic Surgery, Bilkent, Ankara, Turkey
Suleyman Anil Akboga ; University of Health Sciences, Ankara City Hospital, Department of Thoracic Surgery, Bilkent, Ankara, Turkey
Aysegul Inci Sezen ; Istanbul Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Department of Infectious Diseases, Istanbul, Turkey
Serife Gokbulut Bektas ; University of Health Sciences, Ankara City Hospital, Department of Intensive Care Unit, Bilkent, Ankara, Turkey
Yucel Akkas ; University of Health Sciences, Ankara City Hospital, Department of Thoracic Surgery, Bilkent, Ankara, Turkey
Bulent Kocer ; University of Health Sciences, Ankara City Hospital, Department of Thoracic Surgery, Bilkent, Ankara, Turkey

Sažetak

In our study, we examined the effect of COVID-19 vaccination on the incidence
of pneumothorax in intensive care patients over age 65. COVID-19 intensive care patients that presented
to our department between April 2020 and May 2021 during the COVID-19 pandemic were
evaluated retrospectively. Patients were divided into two main groups, i.e., before and after the vaccination
period. Patients were evaluated retrospectively for the following parameters: gender, age, side
of pneumothorax, mortality, discharge, comorbidity, and additional pleural complications. The total
number of patients was 87, i.e., 66 patients before vaccination and 21 patients after vaccination. When
patients in the pre- and post-vaccination period were compared, there was a significant difference in
the incidence of pneumothorax between the two groups (p<0.05). Pneumothorax was less common after
vaccination. When patients with pneumothorax and tube thoracostomy were evaluated according
to pre- and post-vaccination mortality, mortality was significantly higher (89%) in the pre-vaccination
period (p<0.05). We consider that COVID-19 vaccines used in patients aged over 65 reduced the incidence
of pleural complications, especially pneumothorax. We think that mortality due to pneumothorax
in patients over 65 years of age was lower during the vaccination period. In addition, we think that
bilateral pneumothorax was more common in the non-vaccinated period. As a result, we think that
life-threatening pneumothorax and similar complications could be reduced by increasing the number
of vaccines made in the COVID-19 pandemic and spreading it around the world.

Ključne riječi

COVID-19; Pneumothorax; COVID-19 vaccination; Geriatrics; Intensive Care Unit; Mortality

Hrčak ID:

301958

URI

https://hrcak.srce.hr/301958

Datum izdavanja:

1.12.2022.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.410 *